Cytokinetics | CYTK - Pre Tax Profit

Stock Price
62.34
Daily Change
2.10 3.49%
Monthly
-4.71%
Yearly
45.79%
Q1 Forecast
61.24

Cytokinetics reported $-306.18M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 44.6M 4.38M Sep/2025
Amgen USD 3.92B 2.35B Sep/2025
Bayer EUR -1.16B 735M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Cytokinetics USD -306.18M 171.81M Sep/2025
Eisai JPY 14.53B 7.87B Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Exelixis USD 252.41M 22M Sep/2025
Geron USD -18.43M 2.05M Sep/2025
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
Merck USD 6.74B 22M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025